Ketchikan Indian Corporation
Ketchikan Indian Corporation was paid $15.31M by Medicaid between Jan 2018 and Dec 2024, across 62 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 18% of everything it billed.
33Billing provider infoKETCHIKAN INDIAN CORPORATION
KETCHIKAN, AK 99901
KETCHIKAN, AK 99901
33aNPI1821120486assigned 03/09/2007
33bProvider typePharmacist
28Total paid$15.31M
24GClaims39,676
24DCodes billed62
24AFirst – last monthJan 2018 – Dec 2024
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 7,869 | $2.00M | |
| 2019 | 4,970 | $1.74M | |
| 2020 | 6,944 | $2.95M | |
| 2021 | 4,150 | $1.70M | |
| 2022 | 6,311 | $2.57M | |
| 2023 | 4,563 | $1.73M | |
| 2024incomplete | 4,869 | $2.62M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 18% | 6,019 | 4,399 | $2.73M |
| S9484 | Crisis intervention mental health services, per hour | 16% | 5,149 | 1,718 | $2.40M |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 14% | 5,399 | 3,888 | $2.07M |
| H2021 | Community-based wrap-around services, per 15 minutes | 8.3% | 1,933 | 1,092 | $1.27M |
| 99215 | Doctor's office visit, returning patient (complex)Prolong outpt/office vis | 7.2% | 2,321 | 1,843 | $1.10M |
| H2011 | Crisis intervention service, per 15 minutes | 6.0% | 2,314 | 659 | $918K |
| 90837 | Psychotherapy session, about an hourPsychotherapy, 53 minutes with patient | 4.5% | 1,251 | 440 | $687K |
| H2015 | Community support for mental illness or disability, per 15 minutesComprehensive community support services, per 15 minutes | 4.3% | 1,640 | 266 | $661K |
| 80306 | 3.6% | 966 | 496 | $551K | |
| H0015 | Alcohol and/or drug services; intensive outpatient (treatment program that operates at least 3 hours/day and at least 3 days/week and is based on an individualized treatment plan), including assessment, counseling; crisis intervention, and activity therapies or education | 3.5% | 677 | 118 | $538K |
| T1016 | Case management, each 15 minutes | 2.4% | 678 | 280 | $365K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 2.1% | 586 | 516 | $319K |
50 more codes
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 1.6% | 433 | $241K |
| 90832 | Psychotherapy session, about 30 minutes | 1.2% | 223 | $177K |
| 80053 | Comprehensive metabolic panel | 1.1% | 567 | $169K |
| 99441 | 1.1% | 251 | $162K | |
| D0220 | Intraoral - periapical first radiographic image | <1% | 616 | $138K |
| D0140 | Limited oral evaluation - problem focused | <1% | 440 | $127K |
| D1110 | Prophylaxis - adult | <1% | 792 | $98K |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 170 | $77K |
| 99408 | <1% | 113 | $69K | |
| 80305 | <1% | 87 | $68K | |
| T1007 | Alcohol and/or substance abuse services, treatment plan development and/or modification | <1% | 120 | $61K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 138 | $51K |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | <1% | 48 | $45K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 359 | $31K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 53 | $26K |
| H0046 | Mental health services, not otherwise specified | <1% | 168 | $25K |
| H0007 | Alcohol and/or drug services; crisis intervention (outpatient) | <1% | 24 | $23K |
| 99442 | <1% | 33 | $23K | |
| 90834 | Psychotherapy session, about 45 minutes | <1% | 17 | $16K |
| 99443 | <1% | 43 | $16K | |
| D7140 | Extraction, erupted tooth or exposed root | <1% | 67 | $12K |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 229 | $11K |
| H0001 | Alcohol and/or drug assessment | <1% | 12 | $9K |
| D0150 | Comprehensive oral evaluation - new or established patient | <1% | 26 | $8K |
| 0011A | <1% | 55 | $7K | |
| 96127 | <1% | 13 | $7K | |
| D0120 | Dental checkup, returning patient | <1% | 210 | $6K |
| T1023 | Screening to determine the appropriateness of consideration of an individual for participation in a specified program, project or treatment protocol, per encounter | <1% | 24 | $3K |
| D2392 | Resin-based composite - two surfaces, posterior, primary or permanent | <1% | 15 | $3K |
| D8670 | Periodic orthodontic treatment visit | <1% | 132 | $3K |
| D0274 | Bitewings - four radiographic images | <1% | 47 | $2K |
| D1208 | Topical application of fluoride, excluding varnish | <1% | 42 | $2K |
| 0012A | <1% | 65 | $808.00 | |
| 82652 | 0% | 14 | $0.00 | |
| 80061 | Lipid panel | 0% | 133 | $0.00 |
| G0483 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 22 or more drug class(es), including metabolite(s) if performed | 0% | 222 | $0.00 |
| 91300 | 0% | 18 | $0.00 | |
| 84439 | 0% | 27 | $0.00 | |
| 0002A | 0% | 24 | $0.00 | |
| D9999 | Unspecified adjunctive procedure, by report | 0% | 4,301 | $0.00 |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 0% | 97 | $0.00 |
| 82607 | 0% | 25 | $0.00 | |
| D9310 | 0% | 24 | $0.00 | |
| 91301 | 0% | 128 | $0.00 | |
| 0031A | 0% | 16 | $0.00 | |
| 91303 | 0% | 16 | $0.00 | |
| 91305 | 0% | 17 | $0.00 | |
| D0007 | 0% | 12 | $0.00 | |
| 86803 | 0% | 14 | $0.00 | |
| 84443 | Thyroid stimulating hormone (TSH) | 0% | 23 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialROSS, WENDY (RCM)